The anticancer activities 3-(substituted phenyl)-1-[4-(morpholine-4-yl)phenyl]prop-2-en-1-one derivatives were investigated against PC3 (Human Prostate Carcinoma Cell) and HT29 (Human colon colorectal adenocarcinoma) cell lines. The anticancer activity tests were performed by the BrdU ELISA method. 5-Fluorouracil (5-FU) was used as standard compound. Compound 1-7 (except Compound 3) were determined to have higher anticancer activity than 5-FU aganist PC3 cancer cells. IC50 values of the Compounds 1-7 against PC3 cancer cells were 2.53±0.02 µM; 4.40±0.03 µM; 4.36±0.03 µM; 1.76±0.02 µM; 1.78±0.03 µM; 2.31±0.03 µM, respectively.
Gaziantep University Scientific Research Projects Governing Unit (BAPYB) (Project no: FEF.14.01), Turkey
Project no: FEF.14.01
This study was supported by the Gaziantep University Scientific Research Projects Governing Unit (BAPYB) (Project no: FEF.14.01), Turkey
Project no: FEF.14.01
Primary Language | English |
---|---|
Subjects | Structural Biology |
Journal Section | Research Articles |
Authors | |
Project Number | Project no: FEF.14.01 |
Publication Date | June 30, 2021 |
Published in Issue | Year 2021 Volume: 5 Issue: 1 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.